CCIA
CSTL icon

Campbell & Co Investment Adviser’s Castle Biosciences CSTL Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Sell
16,476
-132,348
-89% -$2.95M 0.02% 838
2026
Q1 		$3.65M Buy
+148,824
New +$4.87M 0.21% 133
2025
Q4 		– Sell
-26,996
Closed -$615K – 1176
2025
Q3 		$615K Buy
+26,996
New +$548K 0.05% 631
2025
Q2 		– Sell
-45,849
Closed -$918K – 1184
2025
Q1 		$918K Sell
45,849
-471
-1% -$11.7K 0.07% 465
2024
Q4 		$1.23M Buy
46,320
+6,431
+16% +$196K 0.1% 316
2024
Q3 		$1.14M Buy
39,889
+12,856
+48% +$327K 0.08% 389
2024
Q2 		$589K Buy
+27,033
New +$602K 0.05% 591

Other funds holding CSTL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return

Campbell & Co Investment Adviser's CSTL Position: Q2 2026 in Review

Campbell & Co Investment Adviser reduced its Castle Biosciences (CSTL) stake by 89% in Q2 2026, selling an estimated $2.95M and leaving 16,476 shares worth $393K. The position accounts for 0.02% of the portfolio, ranked #838.

Campbell & Co Investment Adviser first reported a position in CSTL in Q2 2024 and has held it in 7 quarters since. The position peaked at $3.65M in Q1 2026. 38 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Campbell & Co Investment Adviser held 16,476 shares of Castle Biosciences worth $393K as of Q2 2026.
  • Campbell & Co Investment Adviser sold 132,348 Castle Biosciences shares in Q2 2026, an estimated $2.95M.
  • Castle Biosciences made up 0.02% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #838 holding.
  • Campbell & Co Investment Adviser first reported a position in Castle Biosciences in Q2 2024 and has held it in 7 quarters since.
  • Campbell & Co Investment Adviser's Castle Biosciences position peaked at $3.65M in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.